Press release
Deep Brain Stimulation Devices Market Research Report by Geographical Analysis and Forecast to 2020
Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/deep-brain-stimulator-market.html
According to The Parkinson’s Disease Foundation, there are around 10 million people around the world suffering from this condition and more than 1 million of these people are living in America. The global deep brain stimulation devices market for Parkinson’s disease is driven by the expanding geriatric population and the high prevalence of neurological conditions such as Alzheimer’s disease, dementia, and Parkinson’s disease.
In addition to this, the global deep brain stimulation devices market for Parkinson’s disease will be driven by the rising demand for deep brain stimulation (DBS) devices due to the increasing popularity of minimally invasive procedures. DBS surgical therapy is currently the therapy of choice during the advanced stages of the Parkinson’s disease. On the other hand, chemotherapy is recommended generally during the early stages of the disease. Medical practitioners and patients are increasingly choosing DBS over drug therapy as the latter is considered to have several side effects. Furthermore, the efficacy of drug therapy cannot be gauged accurately.
Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
Moreover, the favorable reimbursement scenario is also adding to the growing acceptance of these devices worldwide. The global deep brain stimulation devices market for Parkinson’s disease will also benefit from the rising availability of innovative deep brain stimulation devices.
On the other hand, the global deep brain stimulation devices market for Parkinson’s disease will be challenged by the risks associated with deep brain stimulation procedures. Furthermore, the implementation of certain policies from the government such as the Affordable Care Act in the U.S. will restrict the global deep brain stimulation devices market for Parkinson’s disease.
Download Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1435
Players in the global deep brain stimulation devices market for Parkinson’s disease will benefit from the opportunity provided by the high unmet needs in the emerging economies located in Asia Pacific and other regions. Regionlly, the global deep brain stimulation devices market for Parkinson’s disease is segmented into North America, Asia Pacific, Europe, and Rest of the World.
The global deep brain stimulation devices market for Parkinson’s disease is led by a handful of players. These include: Boston Scientific Corporation, Aleva Neurotherapeutics SA, St. Jude Medical, Inc., and Medtronic, Inc. The research study states that companies by focusing on improving public awareness regarding the disease, related consequences and treatment options can greatly benefit by expanding their reach. Furthermore, hiring CMOs for manufacturing deep brain stimulation devices will also help companies to boost their revenue. Another recommendation from the report is for companies to focus on enhanced product life and reducing prices of DBS devices to create better prospects.
Purchase this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1435<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deep Brain Stimulation Devices Market Research Report by Geographical Analysis and Forecast to 2020 here
News-ID: 877062 • Views: …
More Releases from Transparency Market Research
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036.
Thermal management has become a mission-critical function in…
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036.
Review critical insights and findings from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920
This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,…
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation…
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise.
The global Tablet Hardness Testers…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…
